| Primary |
| Arteriogram Coronary |
23.9% |
| Angiogram |
12.2% |
| Arthrogram |
9.6% |
| Spinal Myelogram |
8.1% |
| Endocarditis |
7.6% |
| Product Used For Unknown Indication |
6.6% |
| Catheterisation Cardiac |
5.6% |
| Anaesthesia |
4.1% |
| Angiogram Cerebral |
4.1% |
| Arteriogram |
3.0% |
| Cardiovascular Evaluation |
2.5% |
| Premedication |
2.0% |
| Cholangitis |
1.5% |
| Coronary Angioplasty |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Hysterosalpingogram |
1.5% |
| Sepsis |
1.5% |
| Angina Pectoris |
1.0% |
| Cardiac Monitoring |
1.0% |
| Chemotherapy |
1.0% |
|
| Hypotension |
8.4% |
| Nausea |
7.4% |
| Urticaria |
7.4% |
| Vomiting |
7.4% |
| Hypersensitivity |
6.3% |
| Shock |
6.3% |
| Anaphylactic Shock |
5.3% |
| Loss Of Consciousness |
5.3% |
| Somnolence |
5.3% |
| Status Epilepticus |
5.3% |
| Off Label Use |
4.2% |
| Oxygen Saturation Decreased |
4.2% |
| Synovitis |
4.2% |
| Wrong Drug Administered |
4.2% |
| Cardio-respiratory Arrest |
3.2% |
| Platelet Count Decreased |
3.2% |
| Pruritus |
3.2% |
| Rash Rubelliform |
3.2% |
| Rhinitis |
3.2% |
| Sensation Of Heaviness |
3.2% |
|
| Secondary |
| Arteriogram Coronary |
18.2% |
| Drug Use For Unknown Indication |
18.2% |
| Product Used For Unknown Indication |
9.1% |
| Anaesthesia |
5.5% |
| Angiogram |
5.5% |
| Cholangitis |
5.5% |
| General Anaesthesia |
5.5% |
| Antibiotic Therapy |
3.6% |
| Coronary Artery Disease |
3.6% |
| Endocarditis |
3.6% |
| Endocarditis Infective |
3.6% |
| Endoscopic Retrograde Cholangiopancreatography |
3.6% |
| Premedication |
3.6% |
| Coronary Angioplasty |
1.8% |
| Ill-defined Disorder |
1.8% |
| Infection Prophylaxis |
1.8% |
| Oedema Peripheral |
1.8% |
| Scan With Contrast |
1.8% |
| Stent Placement |
1.8% |
|
| Laryngeal Dyspnoea |
20.0% |
| Anaphylactic Shock |
10.0% |
| Rash Vesicular |
10.0% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
6.7% |
| Drug Reaction With Eosinophilia And Systemic Symptoms |
6.7% |
| Nausea |
6.7% |
| Renal Failure |
6.7% |
| Renal Failure Chronic |
6.7% |
| Malaise |
3.3% |
| Pericardial Haemorrhage |
3.3% |
| Respiratory Arrest |
3.3% |
| Shock |
3.3% |
| Skin Exfoliation |
3.3% |
| Sneezing |
3.3% |
| Synovitis |
3.3% |
| Vasoplegia Syndrome |
3.3% |
|
| Concomitant |
| Ill-defined Disorder |
21.4% |
| Drug Use For Unknown Indication |
14.3% |
| Acute Coronary Syndrome |
10.7% |
| Catheterisation Cardiac |
10.7% |
| Product Used For Unknown Indication |
10.7% |
| Aortic Valve Replacement |
7.1% |
| Convulsion |
7.1% |
| Acute Myocardial Infarction |
3.6% |
| Angioplasty |
3.6% |
| Coronary Artery Bypass |
3.6% |
| Intra-aortic Balloon Placement |
3.6% |
| Mitral Valve Replacement |
3.6% |
|
| Toxic Skin Eruption |
37.5% |
| Systemic Lupus Erythematosus Rash |
12.5% |
| Acute Generalised Exanthematous Pustulosis |
6.3% |
| Injury |
6.3% |
| Nephrogenic Systemic Fibrosis |
6.3% |
| Rash |
6.3% |
| Renal Failure Chronic |
6.3% |
| Staphylococcal Infection |
6.3% |
| Thrombosis |
6.3% |
| Urinary Tract Infection Fungal |
6.3% |
|
